Skip to content

Effects of Maca Intake on Male Fatigue Resistance and Quality of Life

Effects of Maca Intake on Male Fatigue Resistance and Quality of Life - Effects of Maca Intake on Male Fatigue Resistance and Quality of Life

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059216
Enrollment
50
Registered
2025-11-30
Start date
2025-10-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult males

Interventions

Foods containing maca-derived ingredients Placebo food

Sponsors

Sukoyaka-Kobo Inc.
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) Healthy adult males (2) Individuals with a BMI below 30 kg/m2

Exclusion criteria

Exclusion criteria: (1) Individuals currently receiving medication for any medical condition (2) Individuals consuming foods or health supplements containing the active ingredient of this test food (3) Individuals with functional erectile dysfunction (4) Individuals with serious diseases or psychiatric disorders affecting glucose metabolism, lipid metabolism, liver function, kidney function, heart, circulatory system, respiratory system, endocrine system, immune system, or nervous system; and individuals with a history of such conditions (5) Individuals who have shown abnormal clinical laboratory values in recent health checkups and are deemed unsuitable for trial participation (6) Individuals with currently treated diseases or a history of serious diseases requiring medication (7) Individuals at risk of developing allergies related to the trial (8) Individuals deemed unsuitable as subjects based on responses to the lifestyle questionnaire (9) Individuals participating in other clinical studies at the start of this trial (10) Individuals deemed unsuitable for trial participation by the Principal Investigator (or Study Director)

Design outcomes

Primary

MeasureTime frame
Fatigue-related VAS, Vigar-Activity (VA) using POMS2

Secondary

MeasureTime frame
Salivary testosterone, POMS2 Quality of Life Assessment (excluding Viger-Activity), AMS Score, IIEF5 Score

Countries

Japan

Contacts

Public ContactShigefumi Nibun

EAS inc. Clinical Trial Session

info@eas-ct.jp045-374-3392

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026